Top compounds associated with response to PXDN


Feature Type Standardized
Nominal ANOVA
mRNA AM-580 CTRPv2 pan-cancer AAC 0.059 0.2
mRNA lapatinib gCSI pan-cancer AAC 0.088 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC -0.084 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.2
mRNA Topotecan CTRPv2 pan-cancer AAC -0.05 0.2
mRNA Tipifarnib FIMM pan-cancer AAC -0.2 0.2
mRNA avicin D CTRPv2 pan-cancer AAC 0.081 0.2
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.2
mRNA BI-2536 GDSC1000 pan-cancer AAC 0.086 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.085 0.2
Download CSV